Guardian Pharmacy Services, Inc. (NYSE:GRDN) Stock Has Consensus Price Target of $45.57

Shares of Guardian Pharmacy Services, Inc. (NYSE:GRDN) have received a consensus recommendation of “Moderate Buy” from the ten brokerages that are presently covering the stock, MarketBeat reports. One investment analyst has rated the stock with a hold rating and nine have given a buy rating to the company. The average twelve-month price target among analysts that have covered the stock in the last year is $45.57.

Several analysts have recently commented on GRDN shares. Truist Financial increased their price objective on Guardian Pharmacy Services from $47.00 to $51.00 and gave the stock a “buy” rating in a research note on Monday, September 21st. Oppenheimer lifted their target price on Guardian Pharmacy Services from $43.00 to $49.00 and gave the company an “outperform” rating in a research report on Friday, August 7th. Wall Street Zen downgraded Guardian Pharmacy Services from a “buy” rating to a “hold” rating in a report on Sunday, October 25th. Weiss Ratings lowered Guardian Pharmacy Services from a “buy (b)” rating to a “buy (b-)” rating in a research report on Friday, October 23rd. Finally, KeyCorp initiated coverage on Guardian Pharmacy Services in a research note on Tuesday, September 22nd. They set an “overweight” rating and a $52.00 price objective on the stock.

Guardian Pharmacy Services Price Performance

GRDN opened at $46.77 on Tuesday. Guardian Pharmacy Services has a fifty-two week low of $26.34 and a fifty-two week high of $48.33. The firm has a market capitalization of $2.33 billion, a PE ratio of 39.97, a P/E/G ratio of 2.20 and a beta of 0.06. The company’s 50-day moving average is $41.61 and its 200 day moving average is $38.39.

Guardian Pharmacy Services (NYSE:GRDN) last announced its quarterly earnings results on Thursday, November 5th. The company reported $0.33 earnings per share for the quarter, beating the consensus estimate of $0.31 by $0.02. The business had revenue of $371.07 million for the quarter, compared to analysts’ expectations of $365.76 million. Guardian Pharmacy Services had a net margin of 4.50% and a return on equity of 29.97%. As a group, analysts expect that Guardian Pharmacy Services will post 1.18 EPS for the current year.

Institutional Trading of Guardian Pharmacy Services

Institutional investors and hedge funds have recently made changes to their positions in the company. Jennison Associates LLC lifted its position in shares of Guardian Pharmacy Services by 609.5% during the first quarter. Jennison Associates LLC now owns 822,784 shares of the company’s stock valued at $30,986,000 after purchasing an additional 706,823 shares in the last quarter. Braun Stacey Associates Inc. purchased a new position in Guardian Pharmacy Services during the second quarter worth about $14,234,000. Ranger Investment Management L.P. bought a new stake in Guardian Pharmacy Services in the 2nd quarter worth about $7,263,000. Dimensional Fund Advisors LP grew its position in Guardian Pharmacy Services by 200.0% in the 1st quarter. Dimensional Fund Advisors LP now owns 208,594 shares of the company’s stock worth $7,855,000 after purchasing an additional 139,070 shares in the last quarter. Finally, Sei Investments Co. grew its position in Guardian Pharmacy Services by 40.5% in the 1st quarter. Sei Investments Co. now owns 358,181 shares of the company’s stock worth $13,489,000 after purchasing an additional 103,177 shares in the last quarter.

Guardian Pharmacy Services Company Profile

Guardian Pharmacy Services, Inc provides pharmacy services to people living in long-term care and residential care settings. Its customers include assisted living and skilled nursing communities, behavioral health facilities, and other group-living providers.

The company supplies prescription medications and offers medication packaging, delivery, consulting, and clinical support. Its services are designed to help care providers manage residents’ medication needs and support continuity of care.

Founded in 2004, Guardian operates a network of pharmacies serving communities across the United States.